A Giant Company Seeking to Become the MicroStrategy of This Altcoin Files with the SEC! A $1 Billion Acquisition is on the Way!

While Ethereum (ETH) and many altcoins continue to be adopted by major corporations as part of their treasury strategy, the latest news came for a very surprising altcoin.

At this point, the final move came for Hyperliquid ($HYPE).

Hyperliquid Strategy has filed an S-1 to raise up to $1 billion.

Hyperliquid Strategy, a strategic stockbroker for $HYPE, has filed an S-1 filing with the U.S. Securities and Exchange Commission (SEC) to raise up to $1 billion.

Proceeds will be used for corporate operations and the $HYPE acquisition.

The filing follows the company's formation in July through the merger of Nasdaq-listed biotech firm Sonnet BioTherapeutics and Rorschach I LLC, a special purpose company (SPV).

“The company intends to distribute its $HYPE token holdings selectively, primarily by staking nearly all of its $HYPE holdings. This is expected to yield consistent staking rewards,” the company said in its filing.

As you may recall, Sonnet BioTherapeutics Inc. and Rorschach I LLC, which are traded on Nasdaq, announced last July that they would merge under the name Hyperliquid Strategies Inc. (HSI).

The company currently holds 12.6 million $HYPE and 305 million in cash.

*This is not investment advice.